SV Pharma SRL
SV Pharma reported total assets of 814,509 € at the end of the 2025 financial year (annual accounts filed with the NBB on 17 Jan 2026).
The score of SV Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +346 % Total assets +6 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
SV Pharma's annual accounts
Filed annual accounts
- Year ended 30 Jun 2025filed on 17 Jan 2026
- Year ended 30 Jun 2024filed on 17 Jan 2025
- Year ended 30 Jun 2023filed on 12 Jan 2024
- Year ended 30 Jun 2022filed on 30 Jan 2023
SV Pharma's financial analysis
- Solvency27.0%sector median: 46.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of SV Pharma
SV Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0767.715.111
- VAT number
- BE0767715111
- Peppol
- Registered · 0208:0767715111 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 30 Apr 2021
- Registered office
- 1340 Ottignies-Louvain-la-Neuve
- Latest accounts
- 2025 · filed on 17 Jan 2026
- Activity
- Activities of holding companies (NACE 64210)
SV Pharma (SRL) has been based in Ottignies-Louvain-la-Neuve since 2021, active in: activities of holding companies. For 2025, it reports a net profit of 61,150 € and equity of 220,273 €; its revenue is not published. Its solvency stands at 27.0%, below the median of its sector (46.9%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to SV Pharma
Companies in the same business, of comparable size and area, outside its group.
- Data2Work Activities of holding companies Maaseik · balance sheet 828,323 €
- Elmasi Activities of holding companies Heusden-Zolder · balance sheet 784,158 €
- DB81 Activities of holding companies Antwerp · balance sheet 775,091 €
- Maji Consult Activities of holding companies Mortsel · balance sheet 724,937 €
- Enordics Activities of holding companies Ghent · balance sheet 932,350 €
- Hollevoet Invest Activities of holding companies Veurne · balance sheet 935,380 €
- MIAU Activities of holding companies Heusden-Zolder · balance sheet 938,373 €
- NOPI Activities of holding companies Deinze · balance sheet 675,069 €
Frequently asked questions about SV Pharma
What is the revenue of SV Pharma?
SV Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of SV Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0767715111 for SV Pharma, if the company is VAT-registered. Its company number (CBE) is 0767.715.111.
Where is the registered office of SV Pharma?
According to the CBE register, the registered office of SV Pharma is in 1340 Ottignies-Louvain-la-Neuve.
What is the equity of SV Pharma?
At the close of the 2025 financial year, the equity of SV Pharma amounts to 220,273 €, a solvency of 27.0% of total assets.
Who manages SV Pharma?
The register lists 2 active mandates at SV Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of SV Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →